An Evaluator-blinded Multi-center Study of Combined Treatment With Azzalure/Dysport, Restylane/Emervel Filler and Restylane Skinbooster as Compared to Single Treatment With Either Azzalure/Dysport Alone or Restylane/Emervel Filler Alone
Phase of Trial: Phase IV
Latest Information Update: 12 May 2017
At a glance
- Drugs Botulinum-Toxin-A (Primary) ; Hyaluronic acid (Primary)
- Indications Glabellar lines
- Focus Therapeutic Use
- Sponsors Q-Med
- 08 May 2017 Status changed from active, no longer recruiting to completed.
- 23 Sep 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 27 Nov 2014 New trial record